Follow
Elisabet Gregori-Puigjane
Elisabet Gregori-Puigjane
Investigator at Novartis Institutes of Biomedical Research
Verified email at novartis.com
Title
Cited by
Cited by
Year
Data completeness—the Achilles heel of drug-target networks
J Mestres, E Gregori-Puigjane, S Valverde, RV Sole
Nature biotechnology 26 (9), 983-984, 2008
2772008
The topology of drug–target interaction networks: implicit dependence on drug properties and target families
J Mestres, E Gregori-Puigjané, S Valverde, RV Solé
Molecular BioSystems 5 (9), 1051-1057, 2009
2222009
Identifying mechanism-of-action targets for drugs and probes
E Gregori-Puigjané, V Setola, J Hert, BA Crews, JJ Irwin, E Lounkine, ...
Proceedings of the National Academy of Sciences 109 (28), 11178-11183, 2012
1852012
A ligand-based approach to mining the chemogenomic space of drugs
E Gregori-Puigjané, J Mestres
Combinatorial chemistry & high throughput screening 11 (8), 669-676, 2008
1112008
SHED: Shannon entropy descriptors from topological feature distributions
E Gregori-Puigjané, J Mestres
Journal of chemical information and modeling 46 (4), 1615-1622, 2006
1102006
Ligand-based approach to in silico pharmacology: nuclear receptor profiling
J Mestres, L Martín-Couce, E Gregori-Puigjané, M Cases, S Boyer
Journal of chemical information and modeling 46 (6), 2725-2736, 2006
942006
Conciliating binding efficiency and polypharmacology
J Mestres, E Gregori-Puigjané
Trends in pharmacological sciences 30 (9), 470-474, 2009
682009
Docking and linking of fragments to discover jumonji histone demethylase inhibitors
M Korczynska, DD Le, N Younger, E Gregori-Puigjane, A Tumber, ...
Journal of medicinal chemistry 59 (4), 1580-1598, 2016
552016
Public domain HTS fingerprints: design and evaluation of compound bioactivity profiles from PubChem’s bioassay repository
KY Helal, M Maciejewski, E Gregori-Puigjane, M Glick, AM Wassermann
Journal of chemical information and modeling 56 (2), 390-398, 2016
502016
Coverage and bias in chemical library design
E Gregori-Puigjané, J Mestres
Current opinion in chemical biology 12 (3), 359-365, 2008
402008
New chromene scaffolds for adenosine A2A receptors: Synthesis, pharmacology and structure–activity relationships
F Areias, M Costa, M Castro, J Brea, E Gregori-Puigjané, MF Proença, ...
European journal of medicinal chemistry 54, 303-310, 2012
382012
A chemical screen identifies class a g-protein coupled receptors as regulators of cilia
P Avasthi, A Marley, H Lin, E Gregori-Puigjane, BK Shoichet, ...
ACS chemical biology 7 (5), 911-919, 2012
382012
In silico directed chemical probing of the adenosine receptor family
FM Areias, J Brea, E Gregori-Puigjané, MEA Zaki, MA Carvalho, ...
Bioorganic & medicinal chemistry 18 (9), 3043-3052, 2010
342010
Indexing molecules with chemical graph identifiers
E Gregori‐Puigjané, R Garriga‐Sust, J Mestres
Journal of Computational Chemistry 32 (12), 2638-2646, 2011
152011
Identification of Small Molecule Inhibitors of Amyloid β-Induced Neuronal Apoptosis Acting through the Imidazoline I2 Receptor
M Montolio, E Gregori-Puigjane, D Pineda, J Mestres, P Navarro
Journal of Medicinal Chemistry 55 (22), 9838-9846, 2012
142012
Designing chemical libraries directed to nuclear receptors
E Gregori‐Puigjané, J Mestres
Nuclear Receptors as Drug Targets, 469-488, 2008
22008
Chemoinformatic approaches to target identification
E Gregori-Puigjané, MJ Keiser
Designing multi-target drugs, 50-65, 2012
12012
Identifying Targets for Drugs and Probes with Unknown Mechanisms of Action
E Gregori-Puigjané, V Setola, J Hert, J Evans, BC Crews, E Lounkine, ...
PNAS 109 (28), 11178-11183, 2012
12012
A new Ligand-Based approach to virtual screening, and prolifing or large chemical libraries
E Gregori Puigjané
Universitat Pompeu Fabra, 2008
12008
Virtual fragment screening and linking discovers Jumonji histone demethylase inhibitors
M Korczynska, D Le, M Siklos, N Younger, E Gregori-Puigjane, A Tumber, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–20